Navigation Links
UGA chemistry discovery could have major medical implications

Athens, Ga. The study of an oxygen-sensing bacterial regulatory protein by chemistry researchers at the University of Georgia has provided molecular insight into the oxygen sensing mechanism, which could ultimately lead to a better understanding of the ageing process and new treatments for human diseases such cancer, Parkinson's and Alzheimer's.

Michael Johnson, a distinguished research professor of chemistry in the UGA Franklin College of Arts and Sciences, and Bo Zhang, a UGA chemistry doctoral candidate, have discovered that the fumarate and nitrate reduction regulatory protein, or FNR, in E. coli senses oxygen by a new type of reversible structural change in an iron-sulfur cluster. The work was carried out in collaboration with Nick Le Brun and coworkers from the University of East Anglia. The results were published Sept. 10 in the journal Proceedings of the National Academy of Sciences USA.

Iron-sulfur clusters are abundant biological cofactors that play crucial roles in almost all of fundamental life processes, including respiration, photosynthesis, nitrogen fixation, DNA replication and repair. "Everyone has trillions of iron-sulfur clusters associated with enzymes and proteins in their bodies," Johnson said. "The problem is that they readily degrade in the presence of oxygen and other species that are associated with oxidative stress, leading to loss of protein function."

The research conducted at UGA and UEA focused on FNR, which senses the presence of oxygen in the environment and "switches" off and on specific genes in pathogens, such as E. coli, when there is no oxygen presentconditions often found in the human intestinal tract. Oxygen is sensed by FNR via its iron-sulfur clusterthat undergoes conversion from one form to another, smaller one, thereby causing the protein to change shapethe "switch"and leading to the turning off of genes associated with growth without oxygen.

"E. coli can decide what lifestyle to live, with or without oxygen," said Johnson. "We can't decide to change our need for oxygen, but understanding the mechanisms for reassembly and repair of iron-sulfur clusters in response to oxidative stress is crucial for understanding a host of human diseases as well as the ageing process."

By revealing the structure of the oxygen-damaged cluster in FNR and showing that it can be readily repaired by the addition of iron, this research has discovered a major mechanism for the repair of iron-sulfur clusters. Moreover, preliminary results on other iron-sulfur cluster containing enzymes suggest that this type of iron-sulfur cluster oxygen-damage and repair mechanism is widespread in biology.

Bo Zhang, the lead author on paper said that the iron-sulfur cluster switching mechanism in response to oxygen is smart. "They don't panicthey calmly keep their extra sulfurs and wait to be repaired," said Zhang. She said that any medical applications of the research could take 10 to 20 years for development. The next step is to discover how the repair process works in the cell. Johnson and Zhang are currently working on in vitro models to mimic this biological repair process.

Contact: Michael K. Johnson
University of Georgia

Related medicine news :

1. Heroes of Chemistry: Developed new drugs and technology to cut heating and cooling bills
2. Astex, CRT and the Institute of Cancer Research announce epigenetic drug discovery collaboration
3. Genetic discovery in Montreal for a rare disease in Newfoundland
4. Discovery May Improve Diagnosis of Alzheimers, Parkinsons
5. A vaccine for heart disease? La Jolla Institute discovery points up this possibility
6. SFU duos protein discovery links to cancer research
7. Life Sciences Discovery Fund makes company grants in health-related technologies
8. Evolutionary information improves discovery of mutations associated with diseases
9. Discovery improves understanding of early onset inflammatory disease
10. Discovery explains how cellular pathways converge to regulate food intake and body weight
11. New mouse model helps explain gene discovery in congenital heart disease
Post Your Comments:
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... recover from injury. Recently, he has implemented orthobiologic procedures as a method for ... is one of the first doctors to perform the treatment. Orthobiologics are substances ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... A ... procedures that most people are unfamiliar with. The article goes on to state that ... but also many of these less common operations such as calf and cheek reduction. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Marcy was in a crisis. Her son James, eight, was out ... family verbally and physically. , “When something upset him, he couldn’t control his emotions,” remembers ... would throw rocks at my other children and say he was going to kill them. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Issue 52" report to their offering. ... treatment creates a favourable commercial environment for MedImmune to enter. ... base that will serve to drive considerable growth for effective ... serve to cap sales considerably, but development is still in ...
(Date:6/23/2016)... 2016 , , , WHEN: ... 2016 , , , , LOCATION: , , , Online, ... , , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global ... Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager ... pharmaceutical industry is witnessing an exceptional era. Several new demand spaces, ...
(Date:6/23/2016)... the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. Colombia ... ... Sandra ... ... Astellas is a pharmaceutical company ...
Breaking Medicine Technology: